Brandon Smith
Chief Operating Officer chez PROTHENA CORPORATION PLC
Fortune : - $ au 31/03/2024
Profil
Brandon S.
Smith's current job is Chief Operating Officer at Prothena Corp.
Plc.
Formerly, Mr. Smith worked as Executive Director-Biosimilars Strategy at Amgen, Inc. from 2005 to 2012.
He then held the positions of SVP, VP-Corporate Development & Strategy and Senior VP, VP-Corporate Development & Strategy at Impax Laboratories LLC from 2012 to 2017.
From 2017 to 2020, he served as Chief Operating Officer at Iconic Therapeutics, Inc. Mr. Smith completed his undergraduate degree at the University of Michigan and holds an MBA from the McCombs School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
PROTHENA CORP. PLC
-.--% | 04/03/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Brandon Smith
| Sociétés | Poste | Début |
|---|---|---|
| PROTHENA CORPORATION PLC | Chief Operating Officer | 29/09/2021 |
Anciens postes connus de Brandon Smith
| Sociétés | Poste | Fin |
|---|---|---|
Iconic Therapeutics, Inc.
 Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Chief Operating Officer | 01/01/2020 |
Impax Laboratories LLC
 Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2017 |
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Corporate Officer/Principal | 01/01/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2012 |
Formation de Brandon Smith
| University of Michigan | Undergraduate Degree |
| McCombs School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| AMGEN INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Entreprise privées | 2 |
|---|---|
Impax Laboratories LLC
Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Health Technology |
Iconic Therapeutics, Inc.
Iconic Therapeutics, Inc. BiotechnologyHealth Technology Iconic Therapeutics, Inc. engages in the development of novel therapeutics for the treatment of serious eye disorders. Its product ICON-1, is a novel immune-conjugate fusion protein that works with the body’s immune system to address the root causes of inflammation and angiogenesis together, potentially altering the course of causes of blindness. The company was founded by Alan Garen, Kirk Dornbush, and Michael I. Sherman in 2003 and is headquartered in South San Francisco, CA. | Health Technology |
